Related Experiment Videos

Complement and antibody enhance binding and uptake of HIV-1 by bone marrow cells

B A van de Wiel¹, L J Bakker, L de Graaf

¹Department of Pathology, University Hospital, Utrecht, The Netherlands.

Advances in Experimental Medicine and Biology

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effort.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.

European journal of cancer (Oxford, England : 1990)·2025

Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial.

Immuno-oncology technology·2022

Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

See all related articles